LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma

The current study elucidated the role of a long non‐coding RNA (lncRNA), FOXD2‐AS1, in the pathogenesis of hepatocellular carcinoma (HCC) and the regulatory mechanism underlying FOXD2‐AS1/miR‐150‐5p/transmembrane protein 9 (TMEM9) signalling in HCC. Microarray analysis was used for preliminary scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Chengjun, Dong, Zhitao, Yang, Cheng, Zhang, Minfeng, Dai, Binghua, Geng, Li, Lu, Jiongjiong, Yang, Jiamei, Xu, Minhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714507/
https://www.ncbi.nlm.nih.gov/pubmed/31210410
http://dx.doi.org/10.1111/jcmm.14465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714507/
https://www.ncbi.nlm.nih.gov/pubmed/31210410
http://dx.doi.org/10.1111/jcmm.14465

Ejemplares similares